Director, Hematology Clinical Intelligence & RWE Strategy
Core
Lead end-to-end evidence strategy for the Hematology therapeutic area, aligning RWE and AI capabilities with R&D, regulatory, and market access needs to inform portfolio decisions.
Role type
Director, Clinical Intelligence & RWE Strategy
Builds
Enterprise AI engine for evidence generation and lifecycle intelligence
Domain
Pharma/Biotech, Hematology, Real-World Evidence (RWE), AI/ML
Deliverable
production ML models | dashboards & analysis | client delivery
Required skills
Oncology RWE strategy, Evidence generation methodologies, Multimodal data integration, Regulatory/HTA dossier development, Cross-functional influence, Portfolio decision support
Preferred skills
AI/ML in RWE, Automated evidence synthesis, AI-enabled evidence platforms
Technologies
Genomics, Imaging, Digital endpoints, Pathology AI, Multimodal modeling
Responsibilities
Own Hematology clinical intelligence and RWE strategy from R&D to patient care; Define and prioritize evidence gaps for trial design and external control arms; Partner with Translational Science to integrate multimodal signals for patient stratification; Advance AI-enabled approaches like tumor dynamics forecasting and trial simulation; Convert trial and RWD into insights on standard of care and competitive positioning; Influence global product teams and external partners on evidence outputs.
Seniority
Director, strategic leadership with hands-on technical expertise